Treatment Effectiveness
User reported effectiveness ratings Zanaflex for various conditions.
| Conditions | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
|---|---|---|---|---|---|---|
| Fibromyalgia | 10% | 31% | 8% | 36% | 15% | 39 |
| Lower Back Pain | 5% | 42% | 16% | 26% | 11% | 19 |
| Migraine | 3% | 18% | 10% | 65% | 5% | 40 |
| Neuropathy | 40% | 20% | 0% | 40% | 0% | 5 |
Side Effects
User-reported side effects of Zanaflex
| Side Effect | Percent of Reports Zanaflex |
|---|---|
| Nervousness | 21% |
| Back Pain | 24% |
| Diarrhea | 11% |
| Constipation | 32% |
| Depression | 27% |
| Dry Mouth | 55% |
| Heartburn | 28% |
| Stomach Pain | 10% |
| Addiction | 0% |
| Dizziness | 55% |
| Drowsiness | 79% |
| Increased Muscle Spasms | 21% |
| Rash | 4% |
| Sweating | 28% |
| Tingling Sensation in the Arms, Legs, Hands, and Feet | 24% |
| Vomiting | 4% |
| Weakness | 34% |
Outcomes
Below is the degree of change seen after Zanaflex is higher than average.
|
|
Don't see what you're looking for?
Create a study and help us eradicate suffering!
Outcomes Label
Zanaflex Info
| Property | Value |
|---|---|
| Variable Name | Zanaflex |
| Aggregation Method | SUM |
| Analysis Performed At | 2020-05-04 |
| Duration of Action | 21 days |
| Filling Value | 0 |
| Minimum Allowed Value | 0 count |
| Number of Aggregate Predictors | 0 |
| Number of Aggregate Outcomes | 0 |
| Number of Measurements | 0 |
| Number of Measurements (including those generated by tagged, joined, or child variables) | 0 |
| Public | true |
| Onset Delay | 30 minutes |
| Unit | Count |
| User Variables | 0 |
| Variable Category | Treatments |
| Variable ID | 95943 |